Mayflower Financial Advisors, LLC Baxter International Inc Transaction History

Mayflower Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 19, 2022	BUY	$53.86 - $66.8 $225,834 - $280,092	4,193 New	4,193 $226,000
Q2 2022 Jul 15, 2022	BUY	$63.83 - $80.0 $5,234 - $6,560	82 Added 2.21%	3,793 $244,000
Q1 2022 Apr 21, 2022	SELL	$76.85 - $89.45 $199,809 - $232,570	-2,600 Reduced 41.2%	3,711 $288,000
Q3 2021 Oct 26, 2021	BUY	$73.77 - $83.61 $50,016 - $56,687	678 Added 12.04%	6,311 $503,000
Q4 2020 Apr 12, 2021	BUY	$75.39 - $82.36 $424,671 - $463,933	5,633 New	5,633 $452,000

1,004

452M

1.91M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.1B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.